
Incyte stock rises following EHA presentation acceptance
Investing.com -- Shares of Incyte (NASDAQ:INCY) climbed 7% today after the biopharmaceutical company announced that multiple presentations, including new late-breaking data for its monoclonal antibody INCA033989, have been accepted for presentation at the upcoming European Hematology Association (EHA) congress.The company’s press release detailed that the late-breaking oral presentation will sho ...